Radiation for immunosuppression in human organ transplantation. II. Clinical experience.
D000293:Adolescent; D000328:Adult; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D001769:Blood / Q000528:radiation effects; D002102:Cadaver; D002648:Child; D004285:Dogs; D005112:Extracorporeal Circulation; D005260:Female; D005500:Follow-Up Studies; D006086:Graft vs Host Disease; D006321:Heart / Q000528:radiation effects; D016027:Heart Transplantation; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy; D007668:Kidney / Q000528:radiation effects; D016030:Kidney Transplantation; D008297:Male; D009206:Myocardium / Q000201:enzymology; D011182:Postoperative Care; D011241:Prednisone / Q000627:therapeutic use; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy; D013324:Strontium; D014019:Tissue Donors; D014022:Tissue Survival; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D001379:Azathioprine; D011241:Prednisone; D013324:Strontium